The Sanford Guide to Antimicrobial Therapy 2016

Author: David N. Gilbert
Publisher: Guide to Antimicrobial Therapy
ISBN: 1930808917
Release Date: 2016-05-01
Genre: Medical

Errata Notice: Sanford Guide to Antimicrobial Therapy 2016: Print Edition Content Notices (shipped prior to 5/11/16) Antibacterial Activity Spectra (Table 4, p78): A column shift caused activity data to be displayed incorrectly for Linezolid, Tedizolid, Rifampin (combination), TMP-SMX, Fosfomycin and Metronidazole vs. Anaerobic gram-positive bacteria (the lower right quadrant of the page). A sticker is available to replace the page: http: //www.sanfor dguide.com/support/errata

The Pharmacist s Guide to Antimicrobial Therapy and Stewardship

Author: Sarah M. Wieczorkiewicz
Publisher: ASHP
ISBN: 9781585285211
Release Date: 2015-12-15
Genre: Medical

When a patient comes in with a suspected infectious disease, knowledge is power. Now this knowledge is simplified, comprehensive and easy to find. The Pharmacist's Guide to Antimicrobial Therapy and Stewardship puts all the necessary information in one place, including: Evaluating potentially infected patients Identifying the infection's suspected source and related organisms Comparing the range of anti-infectives Knowing the factors that impact treatment Developing an antimicrobial stewardship program A step-wise approach walks logically from overall key concepts to disease- and drug-specific information. Disease states are summarized for easy reference. Tables make it easy to evaluate recommended treatment options. In infectious disease management, when answers are seldom black and white, this guide helps pharmacists make confident decisions.

The Sanford Guide to Antimicrobial Therapy 2012

Author: David N. Gilbert
Publisher:
ISBN: 1930808720
Release Date: 2012-04-15
Genre: Medical

The 2012 pocket edition is 20% thinner and lighter in weight than the 2011 edition due to new production methods, making the 2012 pocket edition handier than ever. We have also increased contrast of the text for greatly improved readability! The 42nd edition is available in a wide array of formats: the pocket edition, somewhat larger spiral bound edition, and larger library edition in print; Apps for iOS and Android devices; and the Web Edition. The digital editions provide us with a platform to update content regularly as developments warrant. The print editions continue to be our annual -snapshot- of the current state of the field of antimicrobial therapy. Highlights of the 42nd edition include the following areas: Resistance to antibacterial agents is increasing at an alarming pace. Materials on management of resistant gram-positive organisms, such as MRSA, and multi-drug resistant gram-negative bacilli, such as E. coli, (Tables 2, 5 and 6 in print) have been extensively updated and expanded. There is increasing clinical application of continuous, or prolonged, infusion of antibacterials for those drugs where optimal efficacy correlates with time above MIC of the target bacteria: cefepime, ceftazidime, doripenem, meropenem, piperacillin-tazobactam. Hepatitis C (HCV) infects over 175 million people worldwide. Two new HCV protease inhibitors, boceprevir and telaprevir, were approved in 2011 for treatment of HCV. Many more drugs are in development in early 2012. Antiretroviral therapy options continue to expand with the approval of new drugs, such as rilpivirine, and new combination formulations of ARV drugs such as Complera. A newly approved macrolide, fidaxomicin, is included for treatment of moderate to severe C. difficille toxin-mediated diarrhea.

Mayo Clinic Antimicrobial Therapy

Author: John W. Wilson
Publisher: OUP USA
ISBN: 9780199797783
Release Date: 2011-10-26
Genre: Medical

Launching on Oxford Medicine Online in 2012, with the full-text of eight Mayo Clinic Scientific Press (MCSP) print titles and a bank of multiple-choice questions, Mayo Clinic Toolkit provides a single location for resident, fellow, and practicing clinicians to undertake the self-testing necessary to prepare for, and pass, the Boards. The medical management of infectious diseases and antimicrobial therapy can be a daunting task for health care professionals. Mayo Clinic Antimicrobial Therapy: Quick Guide, Second Edition, provides information about infectious diseases and antimicrobial therapy in a format that is readily accessible and easily applicable to the clinical environment. Highlights of this resource include drug dosing recommendations for renal function and renal replacement therapies, drugs of choice for specific organisms (including bacteria, fungi, and viruses), and simplified antimicrobial and management recommendations for specific infectious syndromes. Highlights of The Mayo Clinic Toolkit include: - Each title is presented in an enhanced format, allowing the enlargement and download of all figures and images, and linking to external sources referenced in the text. - The multiple-choice questions are designed to mirror those in the Board exam for realistic preparation; they also link back to the relevant title, and allow the user to measure their development through the recording of practice-exam success. - It can be accessed on a range of internet enabled devices, giving residents, fellows, and practicing clinicians the choice to study in locations which suit them - Subscription lengths range from 1-month to a full year. Combining two complimentary resource types into a single location, with enhancements to the print works, the flexibility to choose where and when to study, and the ability to monitor revision progress, Mayo Clinic Toolkit is truly the go-to site for Board preparation.

The Sanford Guide to Antimicrobial Therapy 2012

Author: David N. Gilbert
Publisher:
ISBN: 1930808704
Release Date: 2012-04-01
Genre: Medical

The 42nd edition of The Sanford Guide to Antimicrobial Therapy is available in a wide array of formats: the pocket edition, somewhat larger spiral bound edition, and larger library edition in print; Apps for iOS and Android devices; and the Web Edition. The digital editions provide us with a platform to update content regularly as developments warrant. The print editions continue to be our annual -snapshot- of the current state of the field of antimicrobial therapy. Highlights of the 42nd edition include the following areas: - Resistance to antibacterial agents is increasing at an alarming pace. Materials on management of resistant gram- positive organisms, such as MRSA, and multi-drug resistant gram-negative bacilli, such as E. coli, (Tables 2, 5 and 6 in print) have been extensively updated and expanded. Despite years of availability, the polymyxin drugs are becoming more important options for treatment of gram-negative infections. Expanded discussion and dosing regimens for Polymyxin B and Polymyxin E (Colistin) are included. - There is increasing clinical application of continuous, or prolonged, infusion of antibacterials for those drugs where optimal efficacy correlates with time above MIC of the target bacteria: cefepime, ceftazidime, doripenem, meropenem, piperacillin-tazobactam. A new table (10D in print) in all editions suggests regimens for continuous or prolonged infusion of these agents. - Hepatitis C (HCV) infects over 175 million people worldwide. Two new HCV protease inhibitors, boceprevir and telaprevir, were approved in 2011 for treatment of HCV. Many more drugs are in development in early 2012. Developments in this field are covered in the 42nd edition, in the Web Edition, in The Sanford Guide to HIV/AIDS Therapy 2012 (20th edition) and in the Sanford Guide to Hepatitis Diagnosis and Treatment App (iOS and Android). - Antiretroviral therapy options continue to expand with the approval of new drugs, such as rilpivirine,

Antibiotics Simplified

Author: Gallagher
Publisher: Jones & Bartlett Publishers
ISBN: 9781284111293
Release Date: 2016-11-21
Genre: Medical

Antibiotics Simplified, Fourth Edition is a best-selling, succinct guide designed to bridge knowledge gained in basic sciences courses with clinical practice in infectious diseases. This practical text reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. It also contains concise Drug Class Reviews with an explanation of the characteristics of various classes of antibacterial drugs and antifungal drugs. This text simplifies learning infectious disease pharmacotherapy and condenses the many facts that are taught about antibiotics into one quick reference guide. This guide will help students learn the characteristics of antibiotics and why an antibiotic is useful for an indication. With an understanding of the characteristics of the antibiotics, students will be able to make a logical choice to treat an infection more easily.